Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Treatment Effects of the Integrated Perinatal Diabetes Education and Management Program
Loral Patchen1,2, Asli McCullers2, Serenity Budd2
1MedStar Washington Hospital Center, Washington, DC.
The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) improved insulin use for pregnant individuals with gestational diabetes mellitus (GDM). The program ensured equitable treatment across racial and ethnic groups.
Area of Science:
- Perinatal health
- Diabetes management
- Health services research
Background:
- Gestational diabetes mellitus (GDM) and pre-existing diabetes pose significant risks during pregnancy.
- Effective management is crucial for improving maternal and infant outcomes.
- The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) was established to address these challenges.
Purpose of the Study:
- To evaluate the treatment outcomes of participants in the IP-DEMP.
- To compare treatment received by IP-DEMP participants with a historical control group.
- To assess the impact of the IP-DEMP on diabetes management in pregnant and postpartum individuals.
Main Methods:
- Retrospective cohort study design.
- Comparison of diabetes treatment between IP-DEMP participants and a historical control group.
- Logistic regression analysis to model treatment associations, adjusting for covariates.
Main Results:
- The analysis included 355 participants; demographic characteristics were similar between groups.
- IP-DEMP participation significantly increased the likelihood of receiving insulin therapy for individuals with GDM.
- No significant disparities in treatment were observed based on racial or ethnic identity.
Conclusions:
- The IP-DEMP effectively increased the use of insulin therapy among individuals with GDM.
- The program demonstrated equitable treatment delivery, irrespective of participants' racial or ethnic background.
- These findings support the IP-DEMP's role in optimizing perinatal diabetes care.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Chronic Pancreatitis II: Collaborative Care
Assessment:

